Cardinal Health Aktie
116,97USD | 1,12USD | 0,97% |
WKN: 880206 / ISIN: US14149Y1082
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99,72 |
The Vanguard Group, Inc. | 12,92 |
Vanguard Group, Inc. (Subfiler) | 12,25 |
SSgA Funds Management, Inc. | 6,01 |
State Street Corp. | 5,86 |
BlackRock Fund Advisors | 3,22 |
Vanguard Total Stock Market ETF | 3,18 |
BlackRock Advisors LLC | 2,71 |
Vanguard 500 Index Fund | 2,67 |
BlackRock Institutional Trust Co. NA | 2,67 |
Geode Capital Management LLC | 2,38 |
Vanguard Mid Cap Index Fund | 2,14 |
Pacer Fds. Tr. - US Cash Cows 100 ETF | 1,80 |
Pacer Advisors, Inc. | 1,77 |
BlackRock Equity Dividend Fund | 1,74 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 48 000 | 47 300 | 46 500 | 48 000 | 48 900 |
Umsatz pro Mitarbeiter in Mio. EUR | 3,19 | 3,44 | 3,90 | 4,27 | 4,64 |
Bilanz (in Mio. USD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 25 940 | 31 048 | 32 935 | 33 833 | 34 884 |
Summe Anlagevermögen | 14 826 | 13 405 | 10 943 | 9 584 | 10 237 |
Summe Aktiva | 40 766 | 44 453 | 43 878 | 43 417 | 45 121 |
Bilanz (in Mio. USD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 38 974 | 42 659 | 44 584 | 46 268 | 48 333 |
Summe Eigenkapital | 1 792 | 1 794 | -706 | -2 851 | -3 212 |
Summe Passiva | 40 766 | 44 453 | 43 878 | 43 417 | 45 121 |
Adresse
7000 Cardinal Place, 43017 Dublin | |
Telefon | +1 (614) 757-5000 |
Internet | http://www.cardinalhealth.com |
Management
Aaron E. Alt
Chief Financial Officer |
Akhil Johri
Independent Director |
Christine Ann Mundkur
Independent Director |
Craig Cowman
EVP-Strategic Sourcing & Manufacturer Services |
David C. Evans
Independent Director |
Debbie Weitzman
Chief Executive Officer-Pharmaceutical Segment |
Dennis David
Vice President-Strategy & Business Development |
Gregory B. Kenny
Independent Non-Executive Chairman |
Jason M. Hollar
Chief Executive Officer & Director |
Jessica L. Mayer
Chief Compliance & Legal Officer |
Lisa Capodici
Vice President-Investor Relations |
Mary C. Scherer
Chief Accounting Officer & Senior Vice President |
Matt Sims
Vice President-Investor Relations |
Michelle D. Greene
Chief Information Officer & Executive VP |
Michelle M. Brennan
Independent Director |
Nancy Killefer
Independent Director |
Ola M. Snow
Chief Human Resources Officer |
Patricia A. Hemingway Hall
Independent Director |
Patrick Pope
Secretary, Executive VP & General Counsel |
Robert W. Azelby
Independent Director |
Sheri H. Edison
Independent Director |
Stephen M. Mason
Chief Executive Officer-Medical Segment |